-
Share
20,920 Posts.
875
10/11/17
09:19
Share
No not at all Pb
IMO
Long term it will come down to the success
of its drugs and how funding is achieved
IMO from reading and research - it is far riskier with biotech’s than solid business in other fields
Dyor
-